TrialJournal of neurology2018

A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine.

Otmar Bayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.